Concomitant Delivery of Histone Deacetylase Inhibitor, MS-275, Enhances the Therapeutic Efficacy of Adoptive T Cell Therapy in Advanced Stage Solid Tumours

Brown, Dominique

Open source

DOI
10.71548/15222
Published
2021
Container
Not recorded
Publisher
McMaster University
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.71548/15222,
  title = {Concomitant Delivery of Histone Deacetylase Inhibitor, MS-275, Enhances the Therapeutic Efficacy of Adoptive T Cell Therapy in Advanced Stage Solid Tumours},
  author = {Brown, Dominique},
  year = {2021},
  doi = {10.71548/15222},
  url = {https://doi.org/10.71548/15222}
}

RIS

TY  - JOUR
TI  - Concomitant Delivery of Histone Deacetylase Inhibitor, MS-275, Enhances the Therapeutic Efficacy of Adoptive T Cell Therapy in Advanced Stage Solid Tumours
AU  - Brown, Dominique
PY  - 2021
DO  - 10.71548/15222
UR  - https://doi.org/10.71548/15222
ER  - 

APA

Dominique, B. (2021). Concomitant Delivery of Histone Deacetylase Inhibitor, MS-275, Enhances the Therapeutic Efficacy of Adoptive T Cell Therapy in Advanced Stage Solid Tumours. https://doi.org/10.71548/15222

Source records